Susceptibilities to 23 antimicrobial agents and β-lactamase production of blood culture isolates of acinetobacter sp in Hong Kong

Scandinavian Journal of Infectious Diseases, Supplement

Volumn , Issue 101, 1996, Pages 21-25

  Ling, Julia M ^a   Ng, Tony K N ^a   Cheng, Augustine F ^a   Norrby, S Ragnar ^b  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AGAR; AMIKACIN; AMINOGLYCOSIDE; AMPICILLIN; ANTIINFECTIVE AGENT; AZTREONAM; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; CARBENICILLIN; CEFOPERAZONE; CEFOTAXIME; CEFPIROME; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORINASE; CIPROFLOXACIN; CLAVULANIC ACID; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; LOMEFLOXACIN; MEROPENEM; NETILMICIN; OFLOXACIN; PIPERACILLIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULBACTAM; SULTAMICILLIN; TOBRAMYCIN;

ACINETOBACTER; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL INFECTION; BLOOD CULTURE; CONTROLLED STUDY; DILUTION; HONG KONG; NONHUMAN; ANTIBIOTIC RESISTANCE; BACTEREMIA; BIOSYNTHESIS; DRUG EFFECT; ENZYMOLOGY; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY;

ACINETOBACTER; BACTEREMIA; BETA-LACTAMASES; DRUG RESISTANCE, MICROBIAL; MICROBIAL SENSITIVITY TESTS;

EID: 0030300198     PISSN: 03008878     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Retailliau HF, Hightower AW, Dixon RE, Allen JR. Acinetobacter calcoaceticus: a nosocomial pathogen with an unusual seasonal pattern. J Infect Dis 139: 371-375, 1979.
2. Bergogne-Berezin E, Joly-Guillou ML. An underestimated nosocomial pathogen, Acinetobacter calcoaceticus. J Antimicrob Chemother 16: 535-538, 1985.
3. Ng KC, Ling JM, Cheng AFB, Norrby SR. A retrospective study of clinical characteristics of Acinetobacter bacteremia. Scand J Infect Dis Suppl 101: 26-32, 1996.
4. Tjernberg I. Antimicrobial susceptibility of Acinetobacter strains identified by DNA-DNA hybridization. APMIS 98: 320-326, 1990.
5. Seifert H, Baginski R, Schulze A, Pulverer G. Antimicrobial susceptibility of Acinetobacter species. Antimicrob Agents Chemother 37: 750-753, 1993.
6. Kuah BG, Kamarasinghe G, Doran J, Chang HR. Antimicrobial susceptibilities of clinical isolates of A. baumannii from Singapore. Antimicrob Agents Chemother 38: 2502-2503, 1994.
7. Vila J, Marcos A, Marco F, Abdalla S, Vergara T, Reig R, Gomez-Lus R, de Anta TJ. In vitro antimicrobial production of β-lactamases, aminoglycoside-modifying enzymes, and chloramphenicol acetyltransferase by and susceptibility of clinical isolates of Acinetobacter baumannii. Antimicrob Agents Chemother 37: 138-141, 1993.
8. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 2nd ed. M7-A2. National Committee for Clinical Laboratory Standards, Villanova, Pa, 1990.
9. British Society for Antimicrobial Chemotherapy. A guide to sensitivity testing. J Antimicrob Chemother 27, Suppl D: 1-50, 1991.
10. Ling JM, Khin-Thi-Oo H, Hui Y-W, French GL. Antimicrobial susceptibilities of Haemophilus species in Hong Kong. J Infect 19: 135-142, 1989.
11. Johnson JL, Anderson RS, Ordal EJ. Nucleic acid homologies among oxidase-negative Moraxella species. J Bacteriol 101: 568-573, 1970.
12. Gerner-Smidt P. Acinetobacter: Epidemiological and taxo-nomic aspects. APMIS 102, Suppl 47: 5-41, 1994.
13. Ling JM, Wise R, Woo THS, Cheng AF. Investigation of the epidemiology of hospital isolates of Acinetobacter anitratus by two molecular methods. J Hosp Inf 32: 29-38, 1996.
14. Moroshoshi T, Saito T. Beta-lactamase and beta-lactam antibiotic resistance in Acinetobacter anitratus (syn. A. calcoaceticus). J Antibiot 30: 969-973, 1977.
15. Blechschmidt B, Borneleit P, Kleber H-P. Purification and characterization of an extracellular β-lactamase produced by Acinetobacter calcoaceticus. J Gen Microbiol 138: 1197-1202, 1992.
16. Hikida M, Yoshida M, Mitsuhashi S, Inoue M. Purification and properties of a cephalosporinase from Acinetobacter calcoaceticus. J Antibiot 42: 123-126, 1989.
17. Hood J, Amyes SGB. A novel method for the identification and distinction of the beta-lactamases of the genus Acinetobacter. J Appl Bacteriol 67: 157-163, 1989.
18. Devaud M, Kayser FH, Bächi B. Transposon-mediated multiple antibiotic resistance in Acinetobacter strains. Antimicrob Agents Chemother 22: 323-329, 1982.
19. Joly-Guillou ML, Vallee E, Bergogne-Berezin E, Philippon A. Distribution of beta-lactamases and phenotype analysis in clinical strains of Acinetobacter calcoaceticus. J Antimicrob Chemother 22: 597-604, 1988.
20. Paul G, Joly-Guillou ML, Bergogne-Berezin E, Névot P, Philippon A. Novel carbenicilin-hydrolyzing β-lactamase (CARB5) from Acinetobacter calcoaceticus var. anitratus. FEMS Microbiol Lett 59: 45-50, 1989.
21. Gutmann L, Kitzis MD, Billot-Klein D, Goldstein F, Nhieu GTV, Lu T, Carlet J, Collatz E, Williamson R. Plasmid-mediated β-lactamase (TEM-7) involved in resistance to ceftazidime and aztreonam. Rev Infect Diseases 10: 860-866, 1988.
22. Redjeb B, Fournier G, Mabilat C, Hassen AB, Philippen A. Two novel transferable extended-spectrum β-lactamases from Klebsiella pneumoniae in Tunisia. FEMS Microbiol Lett 67: 33-38, 1990.
23. Nordmann P, Ronco E, Naas T, Duport C, Michel-Briand Y, Labia R. Characterization of a novel extended-spectrum β-lactamase from Pseudomonas aeruginosa. Antimicrob Agents Chemother 37: 962-969, 1993.
24. Zhou XY, Bordon F, Sirot D, Kitzis M-D, Gutmann L. Emergence of clinical isolates of Escherichia coli producing TEM-1 derivatives or an OXA-1 β-lactamase conferring resistance to β-lactamase inhibitors. Antimicrob Agents Chemother 38: 1085-1089, 1994.
25. Poupart M-C, Chanal C, Sirot D, Labia R, Sirot J. Identification of CTX-2, a novel cefotaximase from a Salmonella mbandaka isolate. Antimicrob Agents Chemother 35: 1498-1500, 1991.
26. Chanal C, Sirot D, Malaure H, Poupart M-C, Sirot J. Sequences of CAZ-3 and CTX-2 extended-spectrum β-lactamase genes. Antimicrob Agents Chemother 36: 1817-1820, 1994.
27. Obana Y, Nishino T. In-vitro and in-vivo activities of sulbactam and YTR830H against Acinetobacter calcoaceticus. J Antimicrob Chemother 26: 677-682, 1990.
28. Urban C, Go E, Mariano N, Berger BJ, Avraham I, Rubin D, Rahal JJ. Effect of sulbactam on infections caused by imipenem-resistant Acinetobacter calcoaceticus biotype anitratus. J Infect Dis 167: 448-451, 1993.
29. Jones RN, Barry AL, Thornsberry C. In vitro studies of meropenem. J Antimicrob Chemother 24, Suppl A: 9-29, 1989.
30. Murray BE, Moellering RC Jr. Evidence of plasmid-mediated production of aminoglycoside-modifying enzymes not previously described in Acinetobacter. Antimicrob Agents Chemother 17: 30-36, 1980.
31. Lambert T, Gerbaud G, Bouvert P, Vieu J-F, Courvalin P. Dissemination of amikacin resistance gene aphA6 in Acinetobacter spp. Antimicrob Agents Chemother 34: 1244-1248, 1990.